Angion’s mission is to deliver effective therapies that heal injured organs and save lives. Our core values include passion, drive, collaboration and innovation. We aim to provide life-changing solutions for patients and their families who would otherwise be faced with irreversible organ damage. Improving the quality of life of patients is one of our primary goals.
A PATIENT Story
"During my childhood, I watched my mother endure two kidney transplants that she needed as a result of her polycystic kidney disease (which I also inherited). Following my first transplant in February 2015, I had complications after 2 ½ months and I had to undergo hemodialysis, awaiting a second transplant. Luckily, 6 months after the first transplant I received my second new kidney. I was blessed enough to receive the gift of life twice!!
"BB3 is a novel drug developed by Angion Biomedica Corp. for renal transplantation. BB3 has the potential to significantly improve function of the transplanted kidney, make the graft last longer and greatly increase the number of transplants being performed.”
- Madhu T., patient